NO20063413L - Nye CC-kjemokinlindrende proteiner - Google Patents

Nye CC-kjemokinlindrende proteiner

Info

Publication number: NO20063413L
Authority: NO; Norway
Prior art keywords: chemokine; new; relieving; proteins; senguineus
Prior art date: 2003-12-24

Application number

NO20063413A

Other languages

English (en)

Norwegian (no)

Inventor

Amanda Proudfoot

Christine Power

Achim Frauenschub

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-24

Filing date

2006-07-24

Publication date

2006-09-25

2006-07-24 Application filed by Applied Research Systems filed Critical Applied Research Systems

2006-09-25 Publication of NO20063413L publication Critical patent/NO20063413L/no

Links

102000001902 CC Chemokines Human genes 0.000 title abstract 3
108010040471 CC Chemokines Proteins 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
241001481703 Rhipicephalus <genus> Species 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
102000023732 binding proteins Human genes 0.000 abstract 1
108091008324 binding proteins Proteins 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
210000003296 saliva Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Insects & Arthropods (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Toxicology (AREA)
Virology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)

NO20063413A 2003-12-24 2006-07-24 Nye CC-kjemokinlindrende proteiner NO20063413L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03104973		2003-12-24
PCT/EP2004/053638 WO2005063812A2 (en)	2003-12-24	2004-12-21	Cc-chemokine-binding tick proteins

Publications (1)

Publication Number	Publication Date
NO20063413L true NO20063413L (no)	2006-09-25

Family

ID=34717258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20063413A NO20063413L (no)	2003-12-24	2006-07-24	Nye CC-kjemokinlindrende proteiner

Country Status (11)

Country	Link
US (1)	US7393660B2 (de)
EP (1)	EP1697404B1 (de)
JP (1)	JP4809242B2 (de)
AT (1)	ATE437179T1 (de)
AU (1)	AU2004309111B2 (de)
CA (1)	CA2544334A1 (de)
DE (1)	DE602004022191D1 (de)
ES (1)	ES2329584T3 (de)
IL (1)	IL176327A (de)
NO (1)	NO20063413L (de)
WO (1)	WO2005063812A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007051781A1 (en) *	2005-10-31	2007-05-10	Laboratoires Serono S.A.	Novel cxc-chemokine antagonists
GB0522298D0 (en) *	2005-11-01	2005-12-07	Natural Environment Res	Agents that bind IgE
EP1984392B1 (de)	2006-02-16	2012-08-08	Merck Serono SA	Neue cc-chemokin-antagonisten
US20100166733A1 (en) *	2006-06-21	2010-07-01	Zurit Levin	Mcp-1 splice variants and methods of using same
WO2008117067A2 (en) *	2007-03-27	2008-10-02	Carl Arne Krister Borrebaeck	Protein signature/markers for the detection of adenocarcinoma
GB202010970D0 (en)	2020-07-16	2020-09-02	Immunovia Ab	Methods, arrays and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5849536A (en) *	1990-03-02	1998-12-15	Bio-Technology General Corp.	Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same
WO2000027873A2 (en) *	1998-11-06	2000-05-18	Research Corporation Technologies, Inc.	Interleukin-2 binding protein from arthropods
WO2001058941A1 (en) *	2000-02-11	2001-08-16	Evolutec Limited	Cytokine activity regulator molecules from tick salivary glands
WO2001078770A1 (en) *	2000-04-14	2001-10-25	The Regents Of The University Of California	Inhibition of transmission of tick-borne infections

2004
- 2004-12-21 EP EP04804972A patent/EP1697404B1/de not_active Expired - Lifetime
- 2004-12-21 WO PCT/EP2004/053638 patent/WO2005063812A2/en not_active Ceased
- 2004-12-21 DE DE602004022191T patent/DE602004022191D1/de not_active Expired - Lifetime
- 2004-12-21 CA CA002544334A patent/CA2544334A1/en not_active Abandoned
- 2004-12-21 ES ES04804972T patent/ES2329584T3/es not_active Expired - Lifetime
- 2004-12-21 AU AU2004309111A patent/AU2004309111B2/en not_active Ceased
- 2004-12-21 AT AT04804972T patent/ATE437179T1/de not_active IP Right Cessation
- 2004-12-21 US US10/583,218 patent/US7393660B2/en not_active Expired - Fee Related
- 2004-12-21 JP JP2006546177A patent/JP4809242B2/ja not_active Expired - Fee Related
2006
- 2006-06-15 IL IL176327A patent/IL176327A/en not_active IP Right Cessation
- 2006-07-24 NO NO20063413A patent/NO20063413L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2004309111A1 (en)	2005-07-14
EP1697404B1 (de)	2009-07-22
WO2005063812A2 (en)	2005-07-14
WO2005063812A3 (en)	2005-10-27
DE602004022191D1 (de)	2009-09-03
US20070224125A1 (en)	2007-09-27
JP2008505604A (ja)	2008-02-28
IL176327A0 (en)	2006-10-05
AU2004309111B2 (en)	2011-02-24
US7393660B2 (en)	2008-07-01
CA2544334A1 (en)	2005-07-14
JP4809242B2 (ja)	2011-11-09
ES2329584T3 (es)	2009-11-27
EP1697404A2 (de)	2006-09-06
IL176327A (en)	2012-03-29
ATE437179T1 (de)	2009-08-15

Similar Documents

Publication	Publication Date	Title
SE9800836D0 (sv)	1998-03-13	New Compounds
DK1206474T3 (da)	2004-10-04	Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
EA200600078A1 (ru)	2006-08-25	Способы и композиции для лечения амилоидных заболеваний
NO20055863L (no)	2001-09-12	W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
CL2004001174A1 (es)	2005-05-06	Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
DK1680507T3 (da)	2011-10-10	Bakterieekspression af proteaseinhibitorer og varianter deraf
NO20025601L (no)	2003-01-06	Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
DE60232251D1 (de)	2009-06-18	Pharmazeutische zusammensetzungen zur behandlung von asthma
TR200200065T2 (tr)	2002-10-21	Dış salgılama bozukluklarının tedavisi için terkip
BRPI0410467A (pt)	2006-05-30	composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
CY1113651T1 (el)	2016-06-22	Αντιφλεγμονωδη σκευασματα
SE0302304D0 (sv)	2003-08-27	Novel compounds
PL1692102T3 (pl)	2013-05-31	Kompozycje i sposoby do wykrywania i leczenia chorób i stanów związanych z receptorami chemokiny
NO20065536L (no)	2006-12-08	Behandling av astma hos barn
NO20042861L (no)	2001-11-22	N-(3-butyn-1-yl)-N-hydroksyurea
DK1478438T3 (da)	2012-08-27	Fremgangsmåder og sammensætninger til behandling af astma
DK1492773T3 (da)	2009-04-14	4-(Heterocyclyl)-benzensulfoximin-forbindelser til behandling af inflammation
WO2002068476A3 (en)	2003-08-07	Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders
NO20063413L (no)	2006-09-25	Nye CC-kjemokinlindrende proteiner
DK1646378T3 (da)	2009-01-19	Farmaceutiske præparater omfattende ascorbinsyre til behandling af superinfektion med svamp og recidiv svamp
NO20063842L (no)	2006-10-20	Silinanforbindelser som cysteinproteaseinhibitorer
NO20044321L (no)	2004-10-12	Piperazinyl- eller piperidinylamin-sulfaminsyreamider som inhibitorer av steroid sulfatase
DE69931784D1 (de)	2006-07-20	Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
WO2003093419A3 (en)	2005-04-28	Preventing secondary lymphedema with vegf-d dna
NO20073773L (no)	2007-09-21	Nye CC-kjemokin antagonister

Legal Events

Date	Code	Title	Description
2008-01-14	CREP	Change of representative	Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS
2013-07-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application